Medivir Overview

  • Founded
  • 1988
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • MVIR B
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $1.15
  • (As of Friday Closing)

Medivir General Information

Description

Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there are opportunities to offer significant improvements to patients. Medivir focuses on the development of MIV-818, a prodrug that has been designed to provide a targeted anti-tumor effect in the liver while minimizing any side effects. Birinapant, a SMAC mimetic, has been out-licensed for development in combination with IGM antibodies for the treatment of solid tumors.

Contact Information

Website
www.medivir.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Lunastigen 5, 2nd floor
  • Box 1086
  • 141 22 Huddinge
  • Sweden
+46 08-546 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medivir Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.15 $1.22 $0.79 - $1.56 $64.2M 55.7M 141K -$0.09

Medivir Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 44,157 15,345 16,024 24,557
Revenue 1,848 1,513 922 2,743
EBITDA (2,634) (4,083) (12,295) (37,261)
Net Income (3,070) (4,622) (13,051) (40,261)
Total Assets 44,201 23,340 31,388 46,653
Total Debt 0 2,010 4,693 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medivir Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas
Drug Discovery
Huddinge, Sweden
9 As of 2021

00000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
0000 000000000
Lund, Sweden
00 As of 0000
00000
000000000 00000

0000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medivir Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioInvent International Formerly VC-backed Lund, Sweden 00 00000 000000000 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
00000 Formerly VC-backed Uppsala, Sweden 000 000.00 00000000 000.00
00000 Corporation Mumbai, India 00000 00000000
00000000000 000000 Private Equity-Backed Raleigh, NC 000 00000 000000 - 000
You’re viewing 5 of 5 competitors. Get the full list »

Medivir Executive Team (18)

Name Title Board Seat Contact Info
Magnus Christensen Interim Chief Executive Officer
Lotta Ferm Interim Chief Financial Officer
Christina Herder Ph.D Executive Vice President & Chief Operating Officer
Daniel Eriksson Ph.D Chief Information Officer
Bo Öberg Ph.D Co-Founder & Shareholder
You’re viewing 5 of 18 executive team members. Get the full list »

Medivir Board Members (1)

Name Representing Role Since
000 00000000 00.0 Medivir Board Member 000 0000
To view Medivir’s complete board members history, request access »

Medivir Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medivir Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 29-Dec-2016 000000000 00000 00 00000 Buildings and Property 000000 000000
0000000000 11-Jun-2011 000000000000000000 0000 Distributors (Healthcare) 000 0000
Presidio Pharmaceuticals 09-Jul-2009 Early Stage VC 0000 Drug Discovery
To view Medivir’s complete investments and acquisitions history, request access »

Medivir Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 11-Jun-2011 000000000000000000 0000 Completed
  • 0000000
To view Medivir’s complete exits history, request access »